Skip to main content

Table 3 Participant characteristics

From: Pressure ulcer multidisciplinary teams via telemedicine: a pragmatic cluster randomized stepped wedge trial in long term care

Variable

Control (N = 67*)

Intervention (N = 94*)

Age

81 (12)

83 (12)

Sex (Female)

43 (64.2%)

65 (69.1%)

Charlson co-morbidities

  

Alzheimer's/Dementia

38 (56.7%)

62 (66.0%)

Diabetes

22 (32.8%)

36 (38.3%)

Stroke/TIA

20 (29.9%)

29 (30.9%)

Diabetes with end organ damage

10 (14.9%)

22 (23.4%)

Paraplegia/Hemiplegia

11 (16.4%)

15 (16.0%)

Any solid tumour

6 (9.0%)

16 (17.0%)

COPD

10 (14.9%)

7 (7.4%)

Congestive Heart Failure

4 (6.0%)

11 (11.7%)

Peripheral Vascular Disease

5 (7.5%)

6 (6.4%)

Myocardial Infarction

3 (4.5%)

6 (6.4%)

Moderate or severe renal disease

1 (1.5%)

4 (4.3%)

Charlson Co-morbidity Index

3 (2)

3 (2)

Other co-morbidities

  

Hypertension

37 (55.2%)

55 (58.5%)

Osteoarthritis

36 (53.7%)

42 (44.7%)

Osteoporosis

23 (34.3%)

33 (35.1%%)

Coronary Artery Disease

15 (22.4%)

18 (19.1%)

Parkinson's disease

7 (10.4%%)

9 (9.6%)

Contractures

5 (7.5%)

6 (6.4%%)

Spasticity

4 (6.0%)

5 (5.3%)

PU Risk factors

  

Incontinence (urine)

66 (98.5%)

91 (96.8%)

Incontinence (stool)

58 (86.6%)

79 (84.0%)

Bedbound

49 (81.7%%)

71 (87.7%)

Mental Status (Not alert/not oriented)

52 (77.6%)

78 (83.0%)

Nutritional supplement

55 (82.1%)

80 (85.1%)

Tube Feed

5 (7.5%)

7 (7.4%)

Body Mass Index

25 (8)

24 (6)

  1. *42 participants crossed study phases, extending from control to intervention i.e. double counted.